Skip to main content

Developing a Pharmacist-Driven Drug-Monitoring Protocol

Conference Correspondent, Audiocast
Audiocasts
Felicia Zook, PharmD, BCOP, discussed her medical practice’s successful development and implementation of a pharmacist-driven drug-monitoring protocol at the 11th annual Hematology/Oncology Pharmacy Association conference.

Related Items

Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain
By Chase Doyle
TOP - August 2017, Vol 10, No 3
Conference Correspondent, HOPA Abstracts, HOPA Abstracts & Highlights
Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation
By Chase Doyle
TOP - August 2017, Vol 10, No 3
Conference Correspondent, HOPA Abstracts, HOPA Abstracts & Highlights
Graft-versus-Host Disease: Breakthroughs on the Horizon
By Chase Doyle
TOP - August 2017, Vol 10, No 3
Conference Correspondent, HOPA Abstracts, HOPA Abstracts & Highlights
Basket Clinical Trials: A New Era in Cancer Treatment
By Chase Doyle
TOP - August 2017, Vol 10, No 3
Conference Correspondent, HOPA Abstracts, HOPA Abstracts & Highlights